계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Geneseeq
company
About
Geneseeq uses NGS technologies to help physicians make meaningful decisions for cancer treatment.
- 11 - 50
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥60M
- Industries
- Biotechnology,Clinical Trials,Health Care,Life Science
- Founded date
- Jan 1, 2008
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Established in 2008, Geneseeq is an industry leader in Next-Generation Sequencing (NGS) fully committed to the research and clinical translation of NGS Genetic Sequencing in the field of personalized medicine.Geneseeq’s world-leading laboratories have successfully passed China’s National Center of Clinical Laboratories(NCCL) External Quality Assessment(EQA), College of American Pathologists(CAP) PT, European Molecular Genetics Quality Network(EMQN) PT, and received 3rd party medical laboratory and clinical PCR amplification laboratory qualifications.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥860M
Geneseeq has raised a total of
¥860M
in funding over 2 rounds. Their latest funding was raised on
Dec 25, 2019 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 25, 2019 | Series D | ¥800M | 2 | — | — | Detail |
| Jul 21, 2017 | Series C | — | 2 | — | — | Detail |
| Jun 1, 2016 | Series B | ¥60M | 1 | — | — | Detail |
Investments
Number of Investments
Number of Lead Investments
2
0
Geneseeq has made 2 investments. Their most recent investment was on
Sep 26, 2014, when MoviePass raised $2.20M.
Investors
Number of Lead Investors
Number of Investors
—
5
Geneseeq is funded by 5 investors.
China Reform Holdings Corporation
and Lilly Asia Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
China Reform Holdings Corporation
|
— | Series D |
Lilly Asia Ventures
|
— | Series D |
|
|
— | Series C |
|
|
— | Series C |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
